Abstract
Purpose
To demonstrate and understand the association of HPV infection and biofilm formation.
Methods
The study consisted of cervicovaginal samples of 72 women who were evaluated at the colposcopy unit. Papanicolaou staining was used for cytological examination while “Crystal Violet Binding” assay was performed to detect biofilm formation.
Results
HPV-DNA was positive in 55.5% (n = 40) of the patients. The biofilm formation rate was statistically significantly higher in the HPV-positive women (45%) compared to HPV-negative women (21.9%) (P < 0.05). There was a statistically significant relationship between the presence of single HPV and “high-risk HPV” types and biofilm formation (P < 0.05). Biofilm formation was found in 80% of women with abnormal smear demonstrating atypical epithelial cells (P < 0.05).
Conclusion
Biofilm formation is more frequent at the cervicovaginal microbiota of patients with HPV infection. This finding is especially important in cases with atypical epithelial cells at their cervicovaginal smears.
Similar content being viewed by others
References
Gheit T. Mucosal and cutaneous human papillomavirus infections and cancer biology. Front Oncol. 2019;9:355.
Hufbauer M, Maltseva M, Meinrath J, Lechner A, Beutner D, Huebbers CU, et al. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer. Int J Cancer. 2018;143:1426–39.
Hufbauer M, Akgül B. Molecular mechanisms of human papillomavirus induced skin carcinogenesis. Viruses. 2017;9:187.
Georgescu SR, Mitran CI, Mitran MI, Caruntu C, Sarbu MI, Matei C, et al. New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress. J Immunol Res. 2018;2018:5315816.
Giuliano AR, Sedjo RL, Roe DJ, Harris R, Baldwin S, Papenfuss MR, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002;13:839–46.
Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127:171–80.
De Araujo Souza PS, Villa LL. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutat Res. 2003;544:375–83.
Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis. 2014;209:1989–99.
Torcia MG. Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci. 2019;20:266.
Zárate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol. 2006;43:174–80.
López D, Vlamakis H, Kolter R. Biofilms. Cold Spring Harb Perspect Biol. 2010;2:a000398.
Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 2019;5:e02192.
Cavalcanti ÉFF, Silva CR, Ferreira DC, Ferreira MVM, Vanderborght PR, Torres MCMB, et al. Detection of human papillomavirus in dental biofilm and the uterine cervix of a pregnant adolescent. Sao Paulo Med J. 2016;134:88–91.
Lee JE, Lee S, Lee H, Song YM, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean Twin Cohort. PLoS ONE. 2013;8:e63514.
Audirac-Chalifour A, Torres-Poveda K, Bahena-Román M, Téllez-Sosa J, Martínez-Barnetche J, Cortina-Ceballos B, et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS ONE. 2016;11:e0153274.
Di Paola M, Sani C, Maria Clemente A, Iossa A, Perissi E, Castronovo G, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7:10200.
Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210:1723–33.
Sahal G, Bilkay IS. Distribution of clinical isolates of Candida spp. and antifungal susceptibility of high biofilm-forming Candida isolates. Rev Soc Bras Med Trop. 2018;51:644–50.
Liang Y, Chen M, Qin L, Wan B, Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infect Agent Cancer. 2019;14:29.
Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: What do we know and where are we going next? Microbiome. 2016;4:58.
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015;6:81.
Leyva-Gómez G, Del Prado-Audelo ML, Ortega-Peña S, Mendoza-Muñoz N, Urbán-Morlán Z, González-Torres M, et al. Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities. Pharmaceutics. 2019;11:E217.
Zahran KM, Agban MN, Ahmed SH, Hassan EA, Sabet MA. Patterns of candida biofilm on intrauterine devices. J Med Microbiol. 2015;64:375–81.
Auler ME, Morreira D, Rodrigues FFO, Abrão MS, Margarido PFR, Matsumoto FE, et al. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis biofilm formation on IUDs in patients with vulvovaginal candidiasis. Med Mycol. 2010;48:211–6.
Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Crit Rev Microbiol. 2017;43:651–67.
Rieth KKS, Gill SR, Lott-Limbach AA, Merkley MA, Botero N, Allen PD, et al. Prevalence of High-risk human papillomavirus in tonsil tissue in healthy adults and colocalization in biofilm of tonsillar crypts. JAMA Otolaryngol Head Neck Surg. 2018;144:231–7.
Zhou Y, Wang L, Pei F, Ji M, Zhang F, Sun Y, et al. Patients with LR-HPV infection have a distinct vaginal microbiota in comparison with healthy controls. Front Cell Infect Microbiol. 2019;9:294.
Kyrgiou M, Mitra A, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. 2017;179:168–82.
Safaeian M, Solomon D, Castle PE. Cervical cancer prevention-cervical screening: science in evolution. Obstet Gynecol Clin N Am. 2007;34:739–60 (ix).
Barut MU, Kale A, Kuyumcuoğlu U, Bozkurt M, Ağaçayak E, Özekinci S, et al. Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions. Med Sci Monit. 2015;21:3860–7.
Tuncer S, Başaran M, Ustaçelebi Ş, Mocan-Kuzey G. High-risk Human Papilloma Virus (HPV) infection determined by Hybrid Capture II Assay in a Turkish university hospital outpatient clinic. Gynecol Obstet Reprod Med. 2006;12:129–34.
Funding
There is no financial support for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
The study was approved by the Hacettepe University Ethics Committee with reference number GO-18 908–09. The study was based in accordance with the Declaration of Helsinki.
Consent to participate
Written informed consent was obtained from the patients.
Consent for publication
All authors read and approved the final manuscript.
Rights and permissions
About this article
Cite this article
Donmez, H.G., Sahal, G., Akgor, U. et al. The relationship between the presence of HPV infection and biofilm formation in cervicovaginal smears. Infection 48, 735–740 (2020). https://doi.org/10.1007/s15010-020-01478-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-020-01478-5